1. Home
  2. SRPT vs LMAT Comparison

SRPT vs LMAT Comparison

Compare SRPT & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

N/A

Current Price

$17.05

Market Cap

2.4B

Sector

Health Care

ML Signal

N/A

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

N/A

Current Price

$106.52

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SRPT
LMAT
Founded
1980
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.0B
IPO Year
2000
2006

Fundamental Metrics

Financial Performance
Metric
SRPT
LMAT
Price
$17.05
$106.52
Analyst Decision
Hold
Buy
Analyst Count
28
5
Target Price
$25.56
$105.80
AVG Volume (30 Days)
2.0M
218.8K
Earning Date
06-01-2026
05-28-2026
Dividend Yield
N/A
0.92%
EPS Growth
N/A
30.57
EPS
N/A
2.52
Revenue
$2,198,237,000.00
$249,602,000.00
Revenue This Year
N/A
$13.66
Revenue Next Year
N/A
$8.97
P/E Ratio
N/A
$42.96
Revenue Growth
15.58
13.53
52 Week Low
$10.42
$71.42
52 Week High
$103.32
$115.33

Technical Indicators

Market Signals
Indicator
SRPT
LMAT
Relative Strength Index (RSI) 42.63 63.99
Support Level $17.05 $81.80
Resistance Level $19.55 $115.33
Average True Range (ATR) 0.86 4.54
MACD 0.14 0.29
Stochastic Oscillator 41.21 68.17

Price Performance

Historical Comparison
SRPT
LMAT

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.

Share on Social Networks: